All participants underwent monocular distance best-corrected VA (BCVA) tests in the study eye using the standard ETDRS (S-ETDRS) charts in clinic and the H-ETDRS device in a simulated home setting.

The primary endpoint is the prevention of =15-letter loss of best corrected visual acuity (BCVA), which represents three lines on the standard Early Treatment of Diabetic Retinopathy Study (ETDRS) eye ...

ANX007 is a first-in-kind, non-pegylated antigen-binding fragment (Fab) designed to block C1q locally in the eye with an intravitreal ... Retinopathy Study (ETDRS) eye chart.

He pointed out that frequent anti-VEGF injections into the eye can be a significant burden ... a mean gain of 10 letters on the visual acuity chart, only half of the trial population achieved ...

All participants were treated with a single intravitreal injection of LUMEVOQ ® in one eye and with sham injection ... of letters patients read on the ETDRS chart, were used for statistical ...

The primary endpoint is the prevention of ≥15-letter loss of best corrected visual acuity (BCVA), which represents three lines on the standard Early Treatment of Diabetic Retinopathy Study (ETDRS) eye ...